Financhill
Sell
17

IVF Quote, Financials, Valuation and Earnings

Last price:
$1.68
Seasonality move :
-8.75%
Day range:
$1.66 - $1.75
52-week range:
$1.38 - $17.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.16x
P/B ratio:
--
Volume:
50K
Avg. volume:
4.6M
1-year change:
-84.08%
Market cap:
$3.7M
Revenue:
$6.5M
EPS (TTM):
-$34.05

Earnings Data

Next earnings date for IVF
Aug 14
2025
Most recent earnings per share
-$12.53
Missed by $12.53
(May 20/2025)
Consensus Estimate
--
(May 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IVF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $1.7M -- -- -- --
05/20/2025 Q1 $1.6M $1.6M -$12.53 -- --
12/31/2024 Q4 $1.5M $1.7M -$9.04 -$3.50 -$5.54
11/19/2024 Q3 -- $1.4M -$5.04 -- --
06/30/2024 Q2 -- $1.8M -$7.44 -- --
03/31/2024 Q1 -- $1.6M -$5.04 -- --
12/31/2023 Q4 -- $1.4M -$9.60 -- --
09/30/2023 Q3 -- $974.9K -$8.40 -- --
06/30/2023 Q2 -- $315.9K -$36.72 -- --
03/31/2023 Q1 -- $348K -$49.20 -- --
12/31/2022 Q4 -- $278.1K -$54.60 -- --
09/30/2022 Q3 -- $235.3K -$50.28 -- --
06/30/2022 Q2 -- $146.1K -$55.44 -- --
03/31/2022 Q1 -- $162.6K -$55.20 -- --
12/31/2021 Q4 -- $3M $7.20 -- --
09/30/2021 Q3 -- $218.9K -$57.60 -- --
06/30/2021 Q2 -- $208.5K -$40.80 -- --
03/31/2021 Q1 -- $684.5K -$60.00 -- --
12/31/2020 Q4 -- $196.6K -$94.82 -- --
09/30/2020 Q3 -- $336.1K -$85.84 -- --
06/30/2020 Q2 -- $246.1K -$64.30 -- --
03/31/2020 Q1 -- $258.6K -$70.31 -- --
12/31/2019 Q4 -- $328.6K -$37.20 -- --
09/30/2019 Q3 -- $303.6K -$35.06 -- --
06/30/2019 Q2 -- $658.6K -$11.93 -- --
03/31/2019 Q1 -- $189.4K -$22.78 -- --
12/31/2018 Q4 -- $155K -$38.40 -- --
09/30/2018 Q3 -- $125K -$15.36 -- --
06/30/2018 Q2 -- $110.2K -$97.15 -- --
03/31/2018 Q1 -- $104.1K -$7.72 -- --
12/31/2017 Q4 -- $81.4K -$10.89 -- --
09/30/2017 Q3 -- $68.2K -$8.07 -- --
06/30/2017 Q2 -- $80.3K -$7.45 -- --
03/31/2017 Q1 -- $52.2K -$11.69 -- --
12/31/2016 Q4 -- $9.5K -$15.10 -- --
09/30/2016 Q3 -- $17.8K -$11.52 -- --
06/30/2016 Q2 -- $5.5K -$79.52 -- --
03/31/2016 Q1 -- $18.1K -$10.16 -- --
12/31/2015 Q4 -- -- -$13.68 -- --
09/30/2015 Q3 -- $2.5K -$6.90 -- --
06/30/2015 Q2 -- $5.6K -$411.14 -- --

INVO Fertility Earnings Questions

  • How Much did INVO Fertility Generate in Revenue Last Quarter?

    INVO Fertility reported $1.6M worth of top line sales in its most recent quarter.

  • Did INVO Fertility Beat Earnings Last Quarter?

    INVO Fertility announced earnings per share of -$12.53 which represents a miss of analyst forecast a -- per share.

  • Is INVO Fertility Profitable?

    INVO Fertility reported $592.3K that represents $0.43 per share over the last quarter.

  • What is the Analyst Consensus for INVO Fertility EPS Next Year?

    INVO Fertility's earnings are forecast to decrease from -$30.19 per share to -$1.11 per share next year representing a decrease of -96.32%.

  • When is INVO Fertility's Earnings Date?

    INVO Fertility's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
84
SBET alert for May 30

SharpLink Gaming [SBET] is down 3.17% over the past day.

Buy
55
RGC alert for May 30

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 7.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock